AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30961424 — intervention group
Group type: EXPERIMENTAL
Intervention: Short video feedback intervention
Number of subjects: 44
Study 30961424 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 28885089 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime history of NSSI and lifetime number of suicide attempts assessed using the Columbia Suicide Severity Rating Scale (C‐SSRS)
Number of subjects: 0
Study 28885089 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime history of attempted suicide and NSSI
Number of subjects: 0
Study 27071140 — intervention group
Group type: EXPERIMENTAL
Intervention: e-PRP injection
Number of subjects: 40
Study 27071140 — intervention group
Group type: COMPARATOR
Intervention: Standard wound care
Number of subjects: 40
Study 25398137 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose Vacc-4x
Number of subjects: 0
Study 25398137 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose Vacc-4x
Number of subjects: 0
Study 25398137 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant alone
Number of subjects: 0
Study 25398137 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacc-4x (all doses)
Number of subjects: 0
Study 23872462 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (ITM) 0.1 mg
Number of subjects: 80
Study 23872462 — intervention group
Group type: COMPARATOR
Intervention: Local infiltration analgesia (LIA) with ropivacaine 300 mg + ketorolac 30 mg + epinephrine 0.5 mg
Number of subjects: 80
Study 20374662 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports chiropractic manual therapy intervention
Number of subjects: 59
Study 20374662 — intervention group
Group type: COMPARATOR
Intervention: Current best practice management (control)
Number of subjects: 59
Study 18491137 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum androgen blockade (MAB) with bicalutamide (Casodex) 80 mg plus LHRHa
Number of subjects: 203
Study 18491137 — intervention group
Group type: COMPARATOR
Intervention: LHRHa monotherapy
Number of subjects: 203
Study 16785404 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdebrider intracapsular tonsillotomy (MT)
Number of subjects: 25
Study 16785404 — intervention group
Group type: COMPARATOR
Intervention: Electrosurgical extracapsular tonsillectomy (ET)
Number of subjects: 25
Study 12563210 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplex ultrasound scan with ultrasound scan contrast agent
Number of subjects: 20
Study 12563210 — intervention group
Group type: COMPARATOR
Intervention: Standard duplex ultrasound scan with color Doppler imaging (CDI)
Number of subjects: 20
Study 10866885 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 83
Study 10866885 — intervention group
Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 83
Study 9432685 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for stages I and II, and in some cases for stage IIIa
Number of subjects: 0
Study 9432685 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational new prognostic factors (K‐ras mutations, Her2/Neu, BCL‐2 protein, p53-expression/mutation)
Number of subjects: 0
Study 1312773 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of folic acid daily for 6 months
Number of subjects: 235
Study 1312773 — intervention group
Group type: COMPARATOR
Intervention: Placebo daily for 6 months
Number of subjects: 235
Study 2862087 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfonylurea
Number of subjects: 195
Study 2862087 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin supplement (ultralente insulin)
Number of subjects: 195
Study 2862087 — intervention group
Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 195
Study 30741865 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonperiodized (NP)
Number of subjects: 54
Study 30741865 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlinear periodized (NLP)
Number of subjects: 54
Study 30741865 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible nonlinear periodized (FNLP)
Number of subjects: 54
Study 30741865 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study 30953549 — intervention group
Group type: EXPERIMENTAL
Intervention: MI/CBT intervention
Number of subjects: 40
Study 30953549 — intervention group
Group type: COMPARATOR
Intervention: WHO mhGAP Intervention Guide for AUDs
Number of subjects: 40
Study 29408866 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol only
Number of subjects: 782
Study 29408866 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen only
Number of subjects: 782
Study 29408866 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of paracetamol and ibuprofen
Number of subjects: 782
Study 27430870 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-oral camera (IOC)
Number of subjects: 78
Study 27430870 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 78
Study 24909628 — intervention group
Group type: EXPERIMENTAL
Intervention: Iliac crest bone grafting (n=11)
Number of subjects: 19
Study 24909628 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP-2 (n=8)
Number of subjects: 19
Study 24909628 — intervention group
Group type: COMPARATOR
Intervention: Control group (Iliac crest bone grafting)
Number of subjects: 19
Study 23184206 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing retraining program (chest physiotherapy group), held once a week for three months
Number of subjects: 0
Study 23184206 — intervention group
Group type: COMPARATOR
Intervention: Subtle Touch program (paired control group)
Number of subjects: 0
Study 20150731 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-week physical activity programme (3 sessions per week, 1 hour each)
Number of subjects: 31
Study 20150731 — intervention group
Group type: COMPARATOR
Intervention: Control group (no physical activities)
Number of subjects: 31
Study 18181974 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimarker real-time reverse transcription-PCR (RT-PCR) for quantification of melanoma markers
Number of subjects: 65
Study 18181974 — intervention group
Group type: EXPERIMENTAL
Intervention: MAGE-3
Number of subjects: 65
Study 18181974 — intervention group
Group type: EXPERIMENTAL
Intervention: Three concordant positive markers
Number of subjects: 65
Study 18181974 — intervention group
Group type: EXPERIMENTAL
Intervention: Two concordant positive markers
Number of subjects: 65
Study 18181974 — intervention group
Group type: EXPERIMENTAL
Intervention: One marker
Number of subjects: 65
Study 15898930 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) 0.2% + alcohol
Number of subjects: 45
Study 15898930 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) 0.05% + cetyl pyridinium chloride (CPC) 0.05% without alcohol
Number of subjects: 45
Study 15898930 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 45
Study 14628599 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once a day for 3 days
Number of subjects: 72
Study 14628599 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment with indwelling catheter and oral antibiotics)
Number of subjects: 72
Study 10369847 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide pretreatment (1 mg)
Number of subjects: 100
Study 10369847 — intervention group
Group type: COMPARATOR
Intervention: No ibutilide pretreatment
Number of subjects: 100
Study 7851584 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor gametes
Number of subjects: 319
Study 7851584 — intervention group
Group type: EXPERIMENTAL
Intervention: Adoption
Number of subjects: 319
Study 7851584 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice of donor source
Number of subjects: 319
Study 7851584 — intervention group
Group type: EXPERIMENTAL
Intervention: Known donor sources
Number of subjects: 319
Study 1782776 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical autologous plasma fibronectin, given 5 times per day for 11 weeks.
Number of subjects: 11
Study 1782776 — intervention group
Group type: COMPARATOR
Intervention: Saline, given 5 times per day for 11 weeks (control group).
Number of subjects: 11
Study 7026262 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 0
Study 7026262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31580727 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers received pedometers
Number of subjects: 50
Study 31580727 — intervention group
Group type: COMPARATOR
Intervention: Control group (mothers did not receive pedometers)
Number of subjects: 50
Study 31823753 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple Suppers intervention
Number of subjects: 140
Study 31823753 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 140
Study 27799456 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke education intervention (lecture, educational flyers, magnetic posters)
Number of subjects: 764
Study 27799456 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 764
Study 26414435 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 38
Study 26414435 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 38
Study 24525257 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐epi‐25‐OH‐D₃
Number of subjects: 155
Study 22748484 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD present
Number of subjects: 4133
Study 22748484 — intervention group
Group type: COMPARATOR
Intervention: No COPD
Number of subjects: 4133
Study 19574176 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1,000 mg) and Vitamin D (400 IU)
Number of subjects: 60
Study 19574176 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1,000 mg) and Vitamin D (400 IU) plus Metformin (1,500 mg)
Number of subjects: 60
Study 19574176 — intervention group
Group type: COMPARATOR
Intervention: Metformin (1,500 mg)
Number of subjects: 60
Study 17291216 — intervention group
Group type: EXPERIMENTAL
Intervention: MMF stop group (reduced and then stopped MMF dose)
Number of subjects: 152
Study 17291216 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued tacrolimus/MMF/steroids triple regimen)
Number of subjects: 152
Study 16236868 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated humidification at CPAP initiation
Number of subjects: 98
Study 16236868 — intervention group
Group type: COMPARATOR
Intervention: Control group (no heated humidification unless upper airway symptoms present)
Number of subjects: 98
Study 12466028 — intervention group
Group type: EXPERIMENTAL
Intervention: S-adenosyl-L-methionine (SAMe) 400 mg/d intramuscularly
Number of subjects: 293
Study 12466028 — intervention group
Group type: COMPARATOR
Intervention: Imipramine (IMI) 150 mg/d orally
Number of subjects: 293
Study 10201428 — intervention group
Group type: COMPARATOR
Intervention: 1H‐MRS with PRESS sequence (TE/TR, 135 ms/2000 ms)
Number of subjects: 12
Study 10201428 — intervention group
Group type: COMPARATOR
Intervention: 1H‐MRS with STEAM sequence (TE/TM/TR, 20 ms/13.7 ms/2000 ms)
Number of subjects: 12
Study 8567842 — intervention group
Group type: COMPARATOR
Intervention: Wash and swim-up method (2 wash cycles in EBSS, 60 min swim-up)
Number of subjects: 15
Study 8567842 — intervention group
Group type: EXPERIMENTAL
Intervention: Two layer Percoll gradient (1 ml semen layered on 36 and 81% Percoll gradient)
Number of subjects: 15
Study 8567842 — intervention group
Group type: EXPERIMENTAL
Intervention: Underlay method (2 wash cycles, resuspended in remaining medium, swim-up for 1 h)
Number of subjects: 15
Study 8567842 — intervention group
Group type: EXPERIMENTAL
Intervention: SpermPrep II method (1 ml semen run through SpermPrep II column)
Number of subjects: 15
Study 2266340 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 65
Study 2266340 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 65
Study 2266340 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Hydrochlorothiazide and Metoprolol
Number of subjects: 65
Study 2266340 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 65
Study 7306434 — intervention group
Group type: EXPERIMENTAL
Intervention: Clenbuterol (40, 60 and 80 micrograms)
Number of subjects: 13
Study 7306434 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (2.5 and 5 mg)
Number of subjects: 13
Study 7306434 — intervention group
Group type: COMPARATOR
Intervention: Clenbuterol and Terbutaline
Number of subjects: 13
Study 7306434 — intervention group
Group type: EXPERIMENTAL
Intervention: Clenbuterol (larger doses)
Number of subjects: 13
Study 30620134 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted prompted voiding (USAPV)
Number of subjects: 80
Study 30620134 — intervention group
Group type: COMPARATOR
Intervention: Conventional prompted voiding (CPV)
Number of subjects: 80
Study 25534063 — intervention group
Group type: EXPERIMENTAL
Intervention: Total frontal reconstruction and transferring of onlay bone grafts to the recessive superior orbital rim (n = 7)
Number of subjects: 12
Study 25534063 — intervention group
Group type: EXPERIMENTAL
Intervention: Total frontal reconstruction and unilateral fronto‐orbital advancement (n = 5)
Number of subjects: 12
Study 25534063 — intervention group
Group type: COMPARATOR
Intervention: Intergroup comparison of both surgical techniques
Number of subjects: 12
Study 24645550 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacoinvasive myocardial reperfusion with prehospital thrombolysis
Number of subjects: 289
Study 24645550 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital thrombolysis before coronary angioplasty
Number of subjects: 289
Study 21120661 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine + 0.000625% adrenalin
Number of subjects: 143
Study 21120661 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine
Number of subjects: 143
Study 21120661 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine
Number of subjects: 143
Study 21120661 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride (control)
Number of subjects: 143
Study 19250100 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic atrial overdrive pacing (algorithm ON-OFF)
Number of subjects: 12
Study 19250100 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic atrial overdrive pacing (algorithm OFF-ON)
Number of subjects: 12
Study 19250100 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study 17908743 — intervention group
Group type: EXPERIMENTAL
Intervention: America on the Move group (n = 100)
Number of subjects: 192
Study 17908743 — intervention group
Group type: COMPARATOR
Intervention: Self-monitor group (n = 92)
Number of subjects: 192
Study 17908743 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (America on the Move and self-monitor)
Number of subjects: 192
Study 17908743 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents in both groups
Number of subjects: 192
Study 15491244 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram plus mirtazapine (15-30 mg/day)
Number of subjects: 49
Study 15491244 — intervention group
Group type: COMPARATOR
Intervention: Citalopram plus placebo
Number of subjects: 49
Study 15491244 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram plus mirtazapine
Number of subjects: 49
Study 11011813 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP Infant Coma Scale (IFS)
Number of subjects: 85
Study 11011813 — intervention group
Group type: COMPARATOR
Intervention: Glasgow Coma Scale (GCS)
Number of subjects: 85
Study 11011813 — intervention group
Group type: COMPARATOR
Intervention: GCS
Number of subjects: 85
Study 11011813 — intervention group
Group type: EXPERIMENTAL
Intervention: IFS
Number of subjects: 85
Study 9157451 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy with RC-Cornet
Number of subjects: 90
Study 9157451 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy with VRP1 Desitin
Number of subjects: 90
Study 9157451 — intervention group
Group type: COMPARATOR
Intervention: Control group (daily 40 mg prednisolon i.v., 2 x theophylline i.v., 3 x inhalation of beta 2+ parasympathicolytic)
Number of subjects: 90
Study 1727093 — intervention group
Group type: COMPARATOR
Intervention: Pyrimethamine plus sulfadiazine (PS)
Number of subjects: 59
Study 1727093 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrimethamine plus clindamycin (PC)
Number of subjects: 59
Study 6238136 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil plus streptozocin (5‐FU plus STZ)
Number of subjects: 172
Study 6238136 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 172
Study 6238136 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin (after crossover from 5‐FU plus STZ)
Number of subjects: 172
Study 6238136 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil plus streptozocin (5‐FU plus STZ) (after crossover from doxorubicin)
Number of subjects: 172
Study 6238136 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 172
Study 31737676 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable powder-supplemented chapatti (VPSC)
Number of subjects: 24
Study 31737676 — intervention group
Group type: EXPERIMENTAL
Intervention: Bean powder-supplemented chapatti (BPSC)
Number of subjects: 24
Study 31737676 — intervention group
Group type: COMPARATOR
Intervention: All-purpose wheat flour chapatti (APFC)
Number of subjects: 24
Study 29024499 — intervention group
Group type: EXPERIMENTAL
Intervention: Men's Club intervention (5-hour interactive educational intervention + weekly text message reminders for 6 weeks)
Number of subjects: 0
Study 29024499 — intervention group
Group type: COMPARATOR
Intervention: Control group (educational pamphlets only)
Number of subjects: 0
Study 29024499 — intervention group
Group type: EXPERIMENTAL
Intervention: Men's Club intervention
Number of subjects: 0
Study 29024499 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 26950082 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 63
Study 26950082 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 63
Study 24612659 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with solifenacin 5 mg and mirabegron (various doses)
Number of subjects: 1306
Study 24612659 — intervention group
Group type: COMPARATOR
Intervention: Solifenacin 5 mg monotherapy
Number of subjects: 1306
Study 24612659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1306
Study 23007324 — intervention group
Group type: EXPERIMENTAL
Intervention: AR-GG27® cream (sorbityl furfural palmitate)
Number of subjects: 100
Study 23007324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 20398559 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug intervention group (hydrochlorothiazide, nitrendipine, and captopril)
Number of subjects: 4984
Study 20398559 — intervention group
Group type: COMPARATOR
Intervention: Control group (health education)
Number of subjects: 4984
Study 20398559 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug intervention group
Number of subjects: 4984
Study 20398559 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 4984
Study 19011219 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief health risk appraisal
Number of subjects: 0
Study 19011219 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 19011219 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 0
Study 15962570 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate statistical analysis of body measurements
Number of subjects: 0
Study 12691602 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary sodium restriction (<80 mmol/day)
Number of subjects: 15
Study 12691602 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 15
Study 10447620 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Analgesia (PCA) with piritramid via PCA pump
Number of subjects: 38
Study 10447620 — intervention group
Group type: COMPARATOR
Intervention: Conventional Pain Therapy (CPT) with tramadol (oral or intramuscularly) or piritramid intravenously
Number of subjects: 38
Study 8665039 — intervention group
Group type: EXPERIMENTAL
Intervention: GER+IMT
Number of subjects: 25
Study 8665039 — intervention group
Group type: EXPERIMENTAL
Intervention: GER
Number of subjects: 25
Study 8665039 — intervention group
Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 25
Study 1687324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% chlorpheniramine
Number of subjects: 13
Study 1687324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% dexbrompheniramine
Number of subjects: 13
Study 1687324 — intervention group
Group type: COMPARATOR
Intervention: 0.3% pheniramine
Number of subjects: 13
Study 1687324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% pheniramine
Number of subjects: 13
Study 1687324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% pheniramine
Number of subjects: 13
Study 1687324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% chlorpheniramine
Number of subjects: 13
Study 1687324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorpheniramine
Number of subjects: 13
Study 1687324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% pyrilamine
Number of subjects: 13
Study 656248 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous breathing
Number of subjects: 16
Study 656248 — intervention group
Group type: COMPARATOR
Intervention: Controlled ventilation with 1% chloroform
Number of subjects: 16
Study 656248 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study 31153095 — intervention group
Group type: EXPERIMENTAL
Intervention: Appeals contesting resistant responses
Number of subjects: 101
Study 31153095 — intervention group
Group type: EXPERIMENTAL
Intervention: Attribution-based manipulation
Number of subjects: 101
Study 28953632 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum PENS
Number of subjects: 62
Study 28953632 — intervention group
Group type: COMPARATOR
Intervention: Sham PENS
Number of subjects: 62
Study 25611898 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopy
Number of subjects: 88
Study 25611898 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 88